Many companies are making progress in cancer research. Seattle Genetics is one of the companies at the forefront of making such progress. There have been numerous reports and news on the strides the company is making when it comes to cancer research. If you have read the reports or news, you will notice that the company has been instrumental in developing innovations that will advance cancer therapy. A good indicator of their effectiveness is that the stock price of Seattle Genetics has tripled since 2012. The company’s CEO, Dr. Clay Siegall, has played a major role.
Who is Dr. Clay Siegall?
The CEO of Seattle Genetics is Dr. Clay Siegall. Since he began a career in biomedical studies, the doctor has been passionate about improving lives of all cancer patients. Currently his duties are the chairman of the board, CEO and president of genetics giant. In 2002, he was the chief executive officer of the company. He served in this position for a number of years before getting additional titles.
Siegall co-founded the company in 1998. This means he has approximately 20 years of history with the company. From 1998, Dr. Clay has been working tirelessly to lead the institution to great advancements in ground-breaking cancer therapies and research in a bid to find a cure for cancer patients.
Siegall has amassed a list of impressive professional accomplishments after he went to George Washington University to get a Ph.D. in Genetics. The (BMSPRI)Bristol-Myers Squibb Pharmaceutical Research Institute was where Clay began his research career. At the institute, he started as a Senior Research Investigator. Later on he was promoted to the Principal Scientist position. Dr. Clay moved on to become a Biotechnology Fellow and Staff Fellow at the national Cancer Institute. He began to prepare for the launch of Seattle genetics after this advancement.
Siegall was named the Pacific Northwest Ernst and Young Entrepreneur of the Year in 2012. He later received the 2013Alumnus of the Year for Natural Sciences, Math and Computer from the University of Maryland. All these were in recognition of Dr. Clay’s significant contributions to the medical and scientific communities.